Phase I study of docetaxel (D) in combination with epirubicin (E) as first line chemotherapy in metastatic breast cancer

被引：0
|
作者：
Borquez, D
Raab, G
Harstrick, A
Wilke, HJ
Achterrath, W
Eiermann, W
Seeber, S
机构：
[1] Rot Kreuz Hosp, Munich, Germany
[2] W German Canc Ctr, Essen, Germany
[3] Rhone Poulenc Rorer, Cologne, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
    Venturini, M
    Bighin, C
    Monfardini, S
    Cappuzzo, F
    Olmeo, N
    Durando, A
    Puglisi, F
    Nicoletto, O
    Lambiase, A
    Del Mastro, L
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 95 (01) : 45 - 53
  • [32] Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
    M. Venturini
    C. Bighin
    S. Monfardini
    F. Cappuzzo
    N. Olmeo
    A. Durando
    F. Puglisi
    O. Nicoletto
    A. Lambiase
    L. Del Mastro
    Breast Cancer Research and Treatment, 2006, 95 : 45 - 53
  • [33] Docetaxel in combination with epirubicin in metastatic breast cancer: pharmacokinetic interactions
    Ceruti, M
    Tagini, V
    Recalenda, V
    Arpicco, S
    Cattel, L
    Airoldi, M
    Bumma, C
    FARMACO, 1999, 54 (11-12): : 733 - 739
  • [34] A phase II study of docetaxel (T) and capecitabine W combination chemotherapy as first-line chemotherapy for patients (pts) with metastatic breast cancer (MBC).
    Lim, HS
    Lee, HG
    Chun, JH
    Lee, JJ
    Lee, JS
    Ro, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 100S - 100S
  • [35] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    Bonneterre, J.
    Campone, M.
    Koralewski, P.
    Blasinska-Morawiec, M.
    Deporte-Fety, R.
    Chatelut, E.
    Leger, F.
    Longerey, B.
    Ecochard, L.
    Douville, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 365 - 373
  • [36] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    J. Bonneterre
    M. Campone
    P. Koralewski
    M. Blasinska-Morawiec
    R. Deporte-Fety
    E. Chatelut
    F. Leger
    B. Longerey
    L. Ecochard
    I. Douville
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 365 - 373
  • [37] Docetaxel in combination chemotherapy for metastatic breast cancer
    Khayat, D
    Antoine, E
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : S19 - S26
  • [38] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    Gamucci, T.
    D'Ottavio, A. M.
    Magnolfi, E.
    Barduagni, M.
    Vaccaro, A.
    Sperduti, I.
    Moscetti, L.
    Belli, F.
    Meliffi, L.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1040 - 1045
  • [39] Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
    T Gamucci
    A M D'Ottavio
    E Magnolfi
    M Barduagni
    A Vaccaro
    I Sperduti
    L Moscetti
    F Belli
    L Meliffi
    British Journal of Cancer, 2007, 97 : 1040 - 1045
  • [40] Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer
    Ejlertsen, B
    Mouridsen, H
    Langkjer, ST
    Andersen, J
    Sjostrom, J
    Kjaer, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S67
12345